Open AccessThe relationship between preliminary efficacy and prognosis after first-line EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment of advanced non-small cell lung cancer
Author(s) -
Dongfang Chen,
Tianqing Chu,
Qing Chang,
Yanwei Zhang,
Liwen Xiong,
Rong Qiao,
Jiajun Teng,
Baohui Han,
Runbo Zhong
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.04.06
Subject(s) - medicine , lung cancer , oncology , tyrosine kinase inhibitor , progression free survival , univariate analysis , retrospective cohort study , multivariate analysis , gastroenterology , cancer , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom